Browsing by Subject "Kinasas Janus"
Now showing items 1-1 of 1
-
(Elsevier, 2017)Objective: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We assessed tofacitinib efficacy and safety in the Latin American (LA) subpopulation of global Phase 3 and long-term ...